Experts
ALL EXPERTSBIOGRAPHY
Antonio Torres is Full Professor in Medicine at the University of Barcelona (UB) and Head of the Respiratory Intesive Care Unit at Hospital Clínic. He is considered a physician of reference both nationally and internationally in lung infections, including pneumonia, chronic obstructive pulmonary disease (COPD), bronchiectasis, immunocompromised patients, weaning, noninvasive ventilation (NIV), and acute respiratory distress syndrome (ARDS-ALI). He leads the research group on Applied Research in Respiratory Diseases of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), from where he facilitates translational research studies. He also coordinates a CIBER group on respiratory diseases (Ciberes) and takes part in several European projects. He is co-author of more than 300 scientific publications and has supervised 24 Phd theses.Research interests Dr. Torres has developed several lines of investigation in the field of respiratory infections and artificial ventilation: 1- Infections in patients in intensive care unit: 2- Infections in patients outside the intensive care unit. 3- Artificial ventilation
Articles
Seasonality of pathogens causing community-acquired pneumonia
Respirology2017Seasonal distribution of microbial aetiology in patients with community-acquired pneumonia (CAP) may add important information both for epidemiologists and clinicians. We investigate the seasonal distribution of microbial aetiology in CAP.
Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease
Respiration.2016In chronic obstructive pulmonary disease (COPD) patients, small-airway dysfunction (SAD) is considered a functional hallmark of disease. However, the exact role of SAD in the clinical presentation of COPD is not yet completely understood; moreover, it is not known whether SAD may have a relationship with the impact of disease.
Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance
Journal of Infection2016OBJECTIVE: Pseudomonas aeruginosa often presents multi-drug resistance (MDR) in intensive care unit (ICU)-acquired pneumonia (ICUAP), possibly resulting in inappropriate empiric treatment and worse outcomes. We aimed to identify patients with ICUAP at risk for these pathogens in order to improve treatment selection and outcomes.
Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial
Physiotherapy2016Objective To compare the efficacy of three slow expiratory airway clearance techniques (ACTs).
Increased incidence of co-infection in critically ill patients with influenza
Intensive Care Medicine2017Co-infection is frequently seen in critically ill patients with influenza, although the exact rate is unknown. We determined the rate of co-infection, the risk factors and the outcomes associated with co-infection in critically ill patients with influenza over a 7-year period in 148 Spanish intensive care units (ICUs).
MORE INFORMATION
Area of Expertise
Acute Respiratory Distress Syndrome (ARDS-ALI)
Artificial Ventilation
Bronchiectasis
COVID-19
Chronic Obstructive Pulmonary Disease (COPD)
Coronavirus
Immunocompromised Patients
Lung Infections
Noninvasive Ventilation (NIV)
Pneumonia
Respiratory Infections
Affiliation
International Bariatric Club - Member
Industry
Research
Education/Learning
Education
Universitat de Barcelona : Hospital Management
Universitat de Barcelona :
Universitat de Barcelona :